Home Cart Sign in  
Chemical Structure| 5142-23-4 Chemical Structure| 5142-23-4

Structure of 3-Methyladenine
CAS No.: 5142-23-4

Chemical Structure| 5142-23-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

3-Methyladenine is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM.

Synonyms: 3-MA; NSC 66389; 3-Methyladenine, NSC 66389

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Zeng, Huating ; Li, Xiaoqi ; Liu, Yuping ; Li, Xia ; Qu, Ding ; Chen, Yan

Abstract: Combinational icaritin (IC) and coix seed oil (CSO) holds promising potential in the treatment of hepatocellular carcinoma. However, traditional cocktail therapy is facing difficulties to optimize the synergistic antitumor efficacy due to the asynchronous pharmacokinetics. Therefore, we developed an icaritin-loaded microemulsion based on coix seed oil (IC-MEs) for improved pharmacokinetics and enhanced antitumor efficacy. The preparation technology of IC-MEs was optimized by the Box–Behnken design and the pharmaceutical properties were characterized in detail. IC-MEs show synergistic antiproliferation against HepG2 cells compared with monotherapy. The mechanism is associated with stronger apoptosis induction via enhancing caspases-3 activity. IC-MEs significantly improve the bioavailability of IC due to the encapsulation of coix oil-based microemulsion and also obtain the desired liver accumulation and elimination. More importantly, IC-MEs exhibit the overwhelming antitumor ability among all of the treatments on the HepG2 xenograft-bearing mice. This study verifies the feasibility of using coix oil-based microemulsion to improve the antitumor effect of water-insoluble components.

Keywords: Icaritin ; coix seed oil-based microemulsion ; hepatocellular carcinoma ; synergistic effect ; autophagy

Purchased from AmBeed:

Alternative Products

Product Details of 3-Methyladenine

CAS No. :5142-23-4
Formula : C6H7N5
M.W : 149.15
SMILES Code : NC1=C2N=CN=C2N(C)C=N1
Synonyms :
3-MA; NSC 66389; 3-Methyladenine, NSC 66389
MDL No. :MFCD00010531
InChI Key :ZPBYVFQJHWLTFB-UHFFFAOYSA-N
Pubchem ID :135398661

Safety of 3-Methyladenine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of 3-Methyladenine

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • p110γ

    PI3Kγ, IC50:60 μM

  • Vps34

    Vps34, IC50:25 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
THLE2 cells 5 mM 6 h To inhibit autophagy and study the protective role of YAP in hepatic ischemia-reperfusion injury. Results showed that inhibition of autophagy weakened YAP-mediated cell protection, accompanied by a significant upregulation of apoptosis levels. Chin Med J (Engl). 2024 Mar 20;137(6):657-668.
mouse primary cortical neurons 5 mM 24 h To inhibit autophagy and evaluate its effect on neuronal survival. Results showed that 3-MA at appropriate concentrations significantly increased neuronal survival after oxygen-glucose deprivation (OGD). J Extracell Vesicles. 2020 Oct;10(1):e12024.
COV434 cells 5 mM 24 h Inhibited autophagy but did not significantly alleviate CDDP-induced ER stress and apoptosis Reprod Biol Endocrinol. 2018 Sep 3;16(1):85.
KGN cells 5 mM 24 h Inhibited autophagy but did not significantly alleviate CDDP-induced ER stress and apoptosis Reprod Biol Endocrinol. 2018 Sep 3;16(1):85.
cardiomyocytes 10 mM 3 h inhibited autophagy, significantly attenuated or ablated lethal toxin-induced cardiomyocyte contractile anomalies BMC Med. 2012 Nov 7;10:134.
osteoclasts 0.5 mM 72 h 3-MA reversed the enhanced autophagy levels by DOX, indicating that enhanced autophagy was responsible for the effects of DOX. Antioxidants (Basel). 2022 Jul 28;11(8):1476.
HEK293T cells 5 mg/mL 8 h To investigate the effect of 3-MA on BinCARD1 degradation, it was found that 3-MA inhibited TBK1-mediated autophagic degradation of BinCARD1. Cell Mol Immunol. 2022 Oct;19(10):1168-1184.
Newborn mouse ovarian cells 1 mM 3 days Inhibited autophagy, leading to a decreased percentage of primordial follicles Cell Death Dis. 2020 Sep 10;11(9):737.
Mouse embryonic fibroblasts (MEFs) 5 mM Inhibition of autophagy, leading to increased toxicity in glucose-starved wild-type MEFs, similar to the effect of RelA inactivation. Nat Cell Biol. 2011 Aug 28;13(10):1272-9.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Hepatic ischemia-reperfusion injury model Intraperitoneal injection 15 mg/kg Once, 1 hour before I/R model establishment To inhibit autophagy and study the protective role of YAP in hepatic ischemia-reperfusion injury. Results showed that inhibition of autophagy weakened YAP-mediated liver protection, accompanied by a significant upregulation of apoptosis levels. Chin Med J (Engl). 2024 Mar 20;137(6):657-668.
C57BL/6 male mice Transverse aortic constriction (TAC)-induced cardiac hypertrophy model Intraperitoneal injection 20 mg/kg Once daily for 4 weeks 3-MA inhibited PKD siRNA-induced increase in autophagy and prevented the ameliorative effects of PKD siRNA on cardiac hypertrophy Int J Biol Sci. 2017 Feb 12;13(3):276-285
C57BL/6 mice Middle cerebral artery occlusion (MCAO) model Intraperitoneal injection 15 mg/kg Single injection at the beginning of reperfusion or 12 hours later To evaluate the inhibitory effect of 3-MA on autophagy after cerebral ischemia and its impact on neuroprotection and neurological recovery. Results showed that 3-MA injection at 12 hours after reperfusion significantly reduced brain injury and improved neurological recovery. J Extracell Vesicles. 2020 Oct;10(1):e12024.
C57BL/6J mice Cisplatin-induced premature ovarian insufficiency model Intraperitoneal injection 10 mg/kg Consecutively for 7 days Inhibiting autophagy did not significantly alleviate CDDP-induced ovarian damage and hormone dysregulation Reprod Biol Endocrinol. 2018 Sep 3;16(1):85.
Mice TAC-induced heart failure model Intraperitoneal injection 15 mg/kg Every 3 days To inhibit autophagic induction and evaluate its effect on TAC-induced heart failure JACC Basic Transl Sci. 2023 Jul 19;8(9):1215-1239
C57BL/6J female mice DOX-induced bone loss model Intraperitoneal injection 5 mg/kg DOX once per week for three weeks; 3-MA daily for four weeks Injection of 3-MA reversed DOX-induced bone loss and reduced the area of OCs on the bone surface. Antioxidants (Basel). 2022 Jul 28;11(8):1476.
Mice Heterotopic transplant model of intestinal fibrosis Intraperitoneal injection 10 mg/kg Once daily for 7 days 3-MA further inhibited autophagy in the grafted tissue and aggravated fibrosis. Cells. 2019 Sep 13;8(9):1078
BALB/C nude mice A2780 tumor xenograft model Not specified 5 mg/kg 3 weeks To investigate the effect of 3-MA on A2780 tumor growth, it was found that 3-MA could completely suppress autophagy induced by the combination of erlotinib and AZD2281 and attenuate its antitumor activity. Drug Des Devel Ther. 2015 Jun 22;9:3183-90

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.70mL

1.34mL

0.67mL

33.52mL

6.70mL

3.35mL

67.05mL

13.41mL

6.70mL

References

 

Historical Records

Categories